000 01671 a2200469 4500
005 20250516141243.0
264 0 _c20130716
008 201307s 0 0 eng d
022 _a1477-7525
024 7 _a10.1186/1477-7525-11-31
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aChen, Hubert
245 0 0 _aTreatment satisfaction is associated with improved quality of life in patients treated with inhaled treprostinil for pulmonary arterial hypertension.
_h[electronic resource]
260 _bHealth and quality of life outcomes
_cMar 2013
300 _a31 p.
_bdigital
500 _aPublication Type: Clinical Trial; Journal Article; Multicenter Study
650 0 4 _aAdministration, Inhalation
650 0 4 _aAdolescent
650 0 4 _aAdult
650 0 4 _aAged
650 0 4 _aAntihypertensive Agents
_xadministration & dosage
650 0 4 _aDrug Administration Schedule
650 0 4 _aEpoprostenol
_xadministration & dosage
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aHypertension, Pulmonary
_xdrug therapy
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aNebulizers and Vaporizers
650 0 4 _aPatient Satisfaction
_xstatistics & numerical data
650 0 4 _aProspective Studies
650 0 4 _aQuality of Life
650 0 4 _aSurveys and Questionnaires
650 0 4 _aTreatment Outcome
700 1 _aRosenzweig, Erika B
700 1 _aGotzkowsky, S Karl
700 1 _aArneson, Carl
700 1 _aNelsen, Andrew C
700 1 _aBourge, Robert C
773 0 _tHealth and quality of life outcomes
_gvol. 11
_gp. 31
856 4 0 _uhttps://doi.org/10.1186/1477-7525-11-31
_zAvailable from publisher's website
999 _c22585933
_d22585933